182 related articles for article (PubMed ID: 2258583)
21. Acute pharmacologic blockade of lipolysis normalizes nocturnal growth hormone levels and pulsatility in obese subjects.
Andreotti AC; Lanzi R; Manzoni MF; Caumo A; Moreschi A; Pontiroli AE
Metabolism; 1994 Oct; 43(10):1207-13. PubMed ID: 7934970
[TBL] [Abstract][Full Text] [Related]
22. Metabolic and endocrine consequences of acute suppression of FFAs by acipimox in polycystic ovary syndrome.
Ciampelli M; Muzj G; Leoni F; Romualdi D; Belosi C; Cento RM; Lanzone A
J Clin Endocrinol Metab; 2001 Nov; 86(11):5324-9. PubMed ID: 11701699
[TBL] [Abstract][Full Text] [Related]
23. Effects of free fatty acids and acipimox, a lipolysis inhibitor, on the somatotroph responsiveness to GHRH in anorexia nervosa.
Gianotti L; Fassino S; Daga GA; Lanfranco F; De Bacco C; Ramunni J; Arvat E; MacCario M; Ghigo E
Clin Endocrinol (Oxf); 2000 Jun; 52(6):713-20. PubMed ID: 10848875
[TBL] [Abstract][Full Text] [Related]
24. Effects of lowering circulating free fatty acid levels on protein metabolism in adult growth hormone deficient patients.
Nielsen S; Jørgensen JO; Hartmund T; Nørrelund H; Nair KS; Christiansen JS; Møller N
Growth Horm IGF Res; 2002 Dec; 12(6):425-33. PubMed ID: 12423628
[TBL] [Abstract][Full Text] [Related]
25. Plasma free fatty acids and serum insulin in subjects feeding at 12-hour intervals; effects of methionyl growth hormone and of acipimox, an inhibitor of lipolysis.
Pontiroli AE; Lanzi R; Monzani M; Musatti L; Guglielmone C; Pozza G
J Endocrinol Invest; 1992 Feb; 15(2):85-91. PubMed ID: 1569294
[TBL] [Abstract][Full Text] [Related]
26. Free fatty acids block growth hormone (GH) releasing hormone-stimulated GH secretion in man directly at the pituitary.
Casanueva FF; Villanueva L; Dieguez C; Diaz Y; Cabranes JA; Szoke B; Scanlon MF; Schally AV; Fernandez-Cruz A
J Clin Endocrinol Metab; 1987 Oct; 65(4):634-42. PubMed ID: 2888782
[TBL] [Abstract][Full Text] [Related]
27. Diagnosis of growth hormone deficiency after pituitary surgery: the combined acipimox/GH-releasing hormone test.
van Dam PS; Dieguez C; Cordido F; de Vries WR; Veldhuyzen BF; van Thiel E; Casanueva FF; Koppeschaar HP
Clin Endocrinol (Oxf); 2003 Feb; 58(2):156-62. PubMed ID: 12580930
[TBL] [Abstract][Full Text] [Related]
28. Intravenous refeeding blocks growth hormone (GH)-provoked rises in serum free fatty acids and blunting of somatotroph response to GH-releasing hormone in normal men.
Rosenbaum M; Fong YM; Hesse DG; Tracey KJ; Hintz RL; Lowry SF; Gertner JM
J Clin Endocrinol Metab; 1989 Aug; 69(2):310-6. PubMed ID: 2502553
[TBL] [Abstract][Full Text] [Related]
29. Effect of acute pharmacological modulation of plasma free fatty acids on GH secretion in acromegalic patients.
Cordido F; Peñalva A; Martinez T; Casanueva FF; Dieguez C
Clin Endocrinol (Oxf); 2001 Apr; 54(4):509-13. PubMed ID: 11318787
[TBL] [Abstract][Full Text] [Related]
30. The effect of free fatty acids on growth hormone (GH)-releasing hormone-mediated GH secretion in man.
Imaki T; Shibasaki T; Shizume K; Masuda A; Hotta M; Kiyosawa Y; Jibiki K; Demura H; Tsushima T; Ling N
J Clin Endocrinol Metab; 1985 Feb; 60(2):290-3. PubMed ID: 3917457
[TBL] [Abstract][Full Text] [Related]
31. Combination therapy with acipimox enhances the effect of growth hormone treatment on linear body growth in the normal and small-for-gestational-age rat.
Vickers MH; Hofman PL; Gluckman PD; Lobie PE; Cutfield WS
Am J Physiol Endocrinol Metab; 2006 Dec; 291(6):E1212-9. PubMed ID: 16803850
[TBL] [Abstract][Full Text] [Related]
32. Acipimox enhances spontaneous growth hormone secretion in obese women.
Kok P; Buijs MM; Kok SW; Van Ierssel IH; Frölich M; Roelfsema F; Voshol PJ; Meinders AE; Pijl H
Am J Physiol Regul Integr Comp Physiol; 2004 Apr; 286(4):R693-8. PubMed ID: 14670810
[TBL] [Abstract][Full Text] [Related]
33. Mediation of the hepatic effects of growth hormone by its lipolytic activity.
Piatti PM; Monti LD; Caumo A; Conti M; Magni F; Galli-Kienle M; Fochesato E; Pizzini A; Baldi L; Valsecchi G; Pontiroli AE
J Clin Endocrinol Metab; 1999 May; 84(5):1658-63. PubMed ID: 10323396
[TBL] [Abstract][Full Text] [Related]
34. Effects of GH replacement therapy in adults on serum levels of leptin and ghrelin: the role of lipolysis.
Vestergaard ET; Hansen TK; Nielsen S; Moller N; Christiansen JS; Jorgensen JO
Eur J Endocrinol; 2005 Oct; 153(4):545-9. PubMed ID: 16189176
[TBL] [Abstract][Full Text] [Related]
35. Effect of antilipolysis on heart and skeletal muscle glucose uptake in overnight fasted humans.
Nuutila P; Knuuti MJ; Raitakari M; Ruotsalainen U; Teräs M; Voipio-Pulkki LM; Haaparanta M; Solin O; Wegelius U; Yki-Järvinen H
Am J Physiol; 1994 Dec; 267(6 Pt 1):E941-6. PubMed ID: 7810638
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological antilipolysis restores insulin sensitivity during growth hormone exposure.
Nielsen S; Møller N; Christiansen JS; Jørgensen JO
Diabetes; 2001 Oct; 50(10):2301-8. PubMed ID: 11574412
[TBL] [Abstract][Full Text] [Related]
37. Short-term acipimox treatment is associated with decreased cardiac parasympathetic modulation.
Vestergaard ET; Cichosz SL; Møller N; Jørgensen JOL; Fleischer J
Br J Clin Pharmacol; 2017 Dec; 83(12):2671-2677. PubMed ID: 28736944
[TBL] [Abstract][Full Text] [Related]
38. Effects on insulin secretion and insulin action of a 48-h reduction of plasma free fatty acids with acipimox in nondiabetic subjects genetically predisposed to type 2 diabetes.
Cusi K; Kashyap S; Gastaldelli A; Bajaj M; Cersosimo E
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1775-81. PubMed ID: 17299078
[TBL] [Abstract][Full Text] [Related]
39. The effect of long-term pharmacological antilipolysis on substrate metabolism in growth hormone (GH)-substituted GH-deficient adults.
Nielsen S; Møller N; Pedersen SB; Christiansen JS; Jørgensen JO
J Clin Endocrinol Metab; 2002 Jul; 87(7):3274-8. PubMed ID: 12107236
[TBL] [Abstract][Full Text] [Related]
40. Enhanced growth hormone (GH) responsiveness to GH-releasing hormone after dietary manipulation in obese and nonobese subjects.
Kelijman M; Frohman LA
J Clin Endocrinol Metab; 1988 Mar; 66(3):489-94. PubMed ID: 3127415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
